Currently, there are 407.58M common shares owned by the public and among those 406.27M shares have been available to trade.
The company’s stock has a 5-day price change of 19.15% and -3.07% over the past three months. PSX shares are trading 10.22% year to date (YTD), with the 12-month market performance down to -14.99% lower. It has a 12-month low price of $91.01 and touched a high of $150.12 over the same period. PSX has an average intraday trading volume of 3.62 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 19.03%, 11.08%, and 1.13% respectively.
Institutional ownership of Phillips 66 (NYSE: PSX) shares accounts for 75.49% of the company’s 407.58M shares outstanding.
It has a market capitalization of $51.16B and a beta (3y monthly) value of 1.01. The stock’s trailing 12-month PE ratio is 28.64, while the earnings-per-share (ttm) stands at $4.38. The company has a PEG of 1.16 and a Quick Ratio of 0.88 with the debt-to-equity ratio at 0.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.68% over the week and 2.76% over the month.
Analysts forecast that Phillips 66 (PSX) will achieve an EPS of 1.74 for the current quarter, 2.03 for the next quarter and 10.29 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.33 while analysts give the company a high EPS estimate of 1.33. Comparatively, EPS for the current quarter was 2.31 a year ago. Earnings per share for the fiscal year are expected to decrease by -24.36%, and 129.30% over the next financial year. EPS should grow at an annualized rate of 24.65% over the next five years, compared to -5.91% over the past 5-year period.
Looking at the support for the PSX, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on May 13, 2025, with the firm’s price target at $114-$120. TD Cowen coverage for the Phillips 66 (PSX) stock in a research note released on April 28, 2025 offered a Buy rating with a price target of $114. Goldman was of a view on March 27, 2025 that the stock is Neutral, while Wolfe Research gave the stock Outperform rating on January 03, 2025, issuing a price target of $143. BofA Securities on their part issued Buy rating on October 17, 2024.
